Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer.

Cell
David A QuigleyFelix Y Feng

Abstract

While mutations affecting protein-coding regions have been examined across many cancers, structural variants at the genome-wide level are still poorly defined. Through integrative deep whole-genome and -transcriptome analysis of 101 castration-resistant prostate cancer metastases (109X tumor/38X normal coverage), we identified structural variants altering critical regulators of tumorigenesis and progression not detectable by exome approaches. Notably, we observed amplification of an intergenic enhancer region 624 kb upstream of the androgen receptor (AR) in 81% of patients, correlating with increased AR expression. Tandem duplication hotspots also occur near MYC, in lncRNAs associated with post-translational MYC regulation. Classes of structural variations were linked to distinct DNA repair deficiencies, suggesting their etiology, including associations of CDK12 mutation with tandem duplications, TP53 inactivation with inverted rearrangements and chromothripsis, and BRCA2 inactivation with deletions. Together, these observations provide a comprehensive view of how structural variations affect critical regulators in metastatic prostate cancer.

References

Mar 3, 2004·Nature Reviews. Cancer·P Andrew FutrealMichael R Stratton
Oct 12, 2004·Biostatistics·Adam B OlshenMichael Wigler
Oct 29, 2005·Science·Scott A TomlinsArul M Chinnaiyan
May 10, 2006·Nature Genetics·Laufey T AmundadottirKari Stefansson
Apr 3, 2007·Nature Genetics·Meredith YeagerGilles Thomas
Jan 13, 2009·Nature·Christopher A MaherArul M Chinnaiyan
Feb 19, 2010·Nature·Graham R BignellMichael R Stratton
Jun 29, 2010·Cancer Cell·Barry S TaylorWilliam L Gerald
Jul 6, 2010·Nucleic Acids Research·Kai WangHakon Hakonarson
Jan 12, 2011·Nature Biotechnology·James T RobinsonJill P Mesirov
Jan 24, 2012·Cell·Christopher A Maher, Richard K Wilson
May 15, 2012·Bioinformatics·Christopher T SaundersR Keira Cheetham
May 23, 2012·Cell·Serena Nik-ZainalUNKNOWN Breast Cancer Working Group of the International Cancer Genome Consortium
May 23, 2012·Nature Genetics·Christopher E BarbieriLevi A Garraway
Jun 23, 2012·Nature·Catherine S GrassoScott A Tomlins
Oct 30, 2012·Bioinformatics·Alexander DobinThomas R Gingeras
Feb 12, 2013·Nature Biotechnology·Kristian CibulskisGad Getz
Mar 16, 2013·Cancer Research·Lia BurkhardtRonald Simon
Apr 30, 2013·Cell·Sylvan C BacaLevi A Garraway
Aug 14, 2013·BMC Bioinformatics·Hongen ZhangSean Davis
Aug 16, 2013·Nature·Ludmil B AlexandrovMichael R Stratton
Sep 28, 2013·Nature Genetics·Travis I ZackRameen Beroukhim
Aug 27, 2014·Genome Biology·Alexander W WyattColin C Collins
Nov 27, 2014·Neoplasia : an International Journal for Oncology Research·John R PrensnerFelix Y Feng
Feb 27, 2015·Nature·Nicola WaddellSean M Grimmond
Apr 2, 2015·Nature·Gunes GundemG Steven Bova
May 23, 2015·Cell·Dan RobinsonArul M Chinnaiyan
May 29, 2015·Nature·Ann-Marie PatchDavid D L Bowtell
Oct 29, 2015·The New England Journal of Medicine·Joaquin MateoJohann S de Bono
Nov 7, 2015·Cell·UNKNOWN Cancer Genome Atlas Research Network
Nov 10, 2015·Nature Genetics·Ludmil B AlexandrovMichael R Stratton
Jan 19, 2016·Nature Reviews. Cancer·Christopher J Lord, Alan Ashworth

❮ Previous
Next ❯

Citations

Dec 7, 2018·Cancer·Corey C FosterSean P Pitroda
Mar 21, 2019·Current Opinion in Oncology·David J EinsteinSteven P Balk
May 8, 2019·Proceedings of the National Academy of Sciences of the United States of America·Wassim AbidaCharles L Sawyers
Mar 29, 2019·Current Oncology Reports·Alejandro AthieJoaquin Mateo
Jun 21, 2019·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J MateoJ S de Bono
Nov 16, 2019·Nature Reviews. Genetics·Steve S HoRyan E Mills
Jan 23, 2020·International Journal of Molecular Sciences·Dangdang LiGuangchao Sui
Feb 11, 2020·International Journal of Cancer. Journal International Du Cancer·Gareth J MorrisonAmir Goldkorn
Jun 20, 2019·PloS One·Deepika SirohiBradley A Stohr
Jun 2, 2020·American Society of Clinical Oncology Educational Book·Benedito A CarneiroRahul Aggarwal
Jun 2, 2020·Oncotarget·Cindy K MirantiElsa M Reyes-Reyes
Apr 26, 2020·Molecular Oncology·Simon J BaumgartBernard Haendler
Jun 4, 2019·Current Opinion in Urology·Zachery R Reichert, Rana R McKay
Dec 1, 2018·Nature Reviews. Urology·Jun Luo, Emmanuel S Antonarakis
Apr 10, 2019·Nature Reviews. Urology·Kevin M KooMatt Trau
Jul 20, 2019·International Journal of Oncology·Shona H LangRuben G W Quek
May 16, 2020·Human Molecular Genetics·Kiel T Tietz, Scott M Dehm
Jul 15, 2020·Nature Genetics·Shuang G ZhaoFelix Y Feng
Jan 20, 2019·Journal of Experimental & Clinical Cancer Research : CR·Chengcheng LvYu Zeng
Apr 7, 2019·Current Genetics·Annie S Tam, Peter C Stirling
Feb 17, 2019·International Journal of Molecular Sciences·Thomas Liehr
Sep 19, 2019·Cell Communication and Signaling : CCS·Disharee NathLeszek Kotula
Oct 9, 2019·Nature Reviews. Urology·Sheng-Yu KuHimisha Beltran
Feb 15, 2020·Nature Communications·Scott WilkinsonAdam G Sowalsky
Dec 12, 2019·Frontiers in Oncology·Matthew J Ryan, Rohit Bose
Jul 22, 2020·Nature Genetics·Mark M PomerantzMatthew L Freedman
May 21, 2020·Quantitative Biology·Wazim Mohammed IsmailHaixu Tang
Jun 24, 2020·Cells·Shujing LiangAirong Qian
Feb 26, 2019·Prostate Cancer and Prostatic Diseases·Nicholas G NickolsMatthew B Rettig
Jul 2, 2019·Frontiers in Oncology·Natalia V BogdanovaThilo Dörk

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

CZI Human Cell Atlas Seed Network

The aim of the Human Cell Atlas (HCA) is to build reference maps of all human cells in order to enhance our understanding of health and disease. The Seed Networks for the HCA project aims to bring together collaborators with different areas of expertise in order to facilitate the development of the HCA. Find the latest research from members of the HCA Seed Networks here.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.

Cell eTOC

Cell is a scientific journal publishing research across a broad range of disciplines within the life sciences field. Discover the latest research from Cell here.

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.